Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (51-60 of 497) with videos related to

Pageof 50
Sort By:
Urologia Internationalis|March 27, 2009
Health-related quality of life in patients with hormone refractory prostate cancer receiving gefitinibGiuseppe Curigliano, Gianluca Spitaleri, Ottavio De Cobelli, et al.
Critical Reviews in Oncology/Hematology|March 3, 2009
Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectivesGabriele Capurso, Nicola Fazio, Stefano Festa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Do we really need another epidermal growth factor receptor tyrosine kinase inhibitor in first-line treatment for patients with non-small-cell lung cancer and EGFR mutations?Eva R Haspinger, Marina Chiara Garassino, Valter Torri, et al.
Critical Reviews in Oncology/Hematology|February 28, 2018
Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectivesClaudio Vernieri, Federico Nichetti, Alessandra Raimondi, et al.
The International Journal of Biological Markers|October 3, 2017
Clinical implications for pro-GRP in small cell lung cancer. A single center experienceStefano Cavalieri, Daniele Morelli, Antonia Martinetti, et al.
Therapeutic Advances in Medical Oncology|September 2, 2016
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factorsElena Verzoni, Paolo Grassi, Raffaele Ratta, et al.
Breast (Edinburgh, Scotland)|April 28, 2016
Waiting for Godot: Predictive factors for adjuvant treatment of patients with luminal breast cancerSerena Di Cosimo, Giacomo Bregni, Maria Grazia Daidone, et al.
Clinical Genitourinary Cancer|June 25, 2013
Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian centerPaolo Grassi, Elena Verzoni, Luigi Mariani, et al.
Critical Reviews in Oncology/Hematology|July 11, 2003
Malignant melanomaFilippo de Braud, David Khayat, Bin B R Kroon, et al.
Critical Reviews in Oncology/Hematology|February 24, 2009
Gastric cancerVincenzo Catalano, Roberto Labianca, Giordano D Beretta, et al.
Pageof 50

Showing results (51-60 of 497) with videos related to

Sort By:
Pageof 50
Urologia Internationalis|March 27, 2009
Health-related quality of life in patients with hormone refractory prostate cancer receiving gefitinibGiuseppe Curigliano, Gianluca Spitaleri, Ottavio De Cobelli, et al.
Critical Reviews in Oncology/Hematology|March 3, 2009
Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectivesGabriele Capurso, Nicola Fazio, Stefano Festa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Do we really need another epidermal growth factor receptor tyrosine kinase inhibitor in first-line treatment for patients with non-small-cell lung cancer and EGFR mutations?Eva R Haspinger, Marina Chiara Garassino, Valter Torri, et al.
Critical Reviews in Oncology/Hematology|February 28, 2018
Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectivesClaudio Vernieri, Federico Nichetti, Alessandra Raimondi, et al.
The International Journal of Biological Markers|October 3, 2017
Clinical implications for pro-GRP in small cell lung cancer. A single center experienceStefano Cavalieri, Daniele Morelli, Antonia Martinetti, et al.
Therapeutic Advances in Medical Oncology|September 2, 2016
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factorsElena Verzoni, Paolo Grassi, Raffaele Ratta, et al.
Breast (Edinburgh, Scotland)|April 28, 2016
Waiting for Godot: Predictive factors for adjuvant treatment of patients with luminal breast cancerSerena Di Cosimo, Giacomo Bregni, Maria Grazia Daidone, et al.
Clinical Genitourinary Cancer|June 25, 2013
Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian centerPaolo Grassi, Elena Verzoni, Luigi Mariani, et al.
Critical Reviews in Oncology/Hematology|July 11, 2003
Malignant melanomaFilippo de Braud, David Khayat, Bin B R Kroon, et al.
Critical Reviews in Oncology/Hematology|February 24, 2009
Gastric cancerVincenzo Catalano, Roberto Labianca, Giordano D Beretta, et al.
Pageof 50